RENEGADEMEDICINE / DR. JEFF MARTINEAU

IV therapy

Infusion care. A personalized approach.

From nutrient support to selected medications, IV therapy begins with a clinical reason, a considered plan, and time to understand your options.

Access to IV care

New to the clinic?

Many IV services are available even if you are not currently a patient of the clinic. We offer a brief IV intake to review safety, clinical indications, and recent laboratory work before treatment.

Specialized IV therapies are also available to people who are not currently clinic patients, by referral from their primary care provider.

Ask about IV intake ↗

Start with the reason for treatment.

Your symptoms, diagnosis, relevant bloodwork, medications, allergies, and previous treatment help determine whether an infusion belongs in your care. We discuss the intended purpose, alternatives, evidence, and monitoring before choosing a treatment.

IV nutrients & hydration.

Nutrient infusions and IV fluids may be considered for individual clinical needs. The formulation, dose, and frequency are selected after assessment, with attention to nutritional status, fluid balance, kidney function, and other relevant health factors. Oral nutrition and hydration remain part of the discussion.

IV iron.

Iron infusions are considered when iron deficiency is established and an IV approach is appropriate. Care includes reviewing the cause of the deficiency, previous oral iron treatment, relevant laboratory findings, and follow-up testing.

IV chelation & IV Plaque X.

These options require a separate discussion of their purpose and the evidence for the proposed use. Chelation has established roles in certain confirmed metal poisonings; it is not a general detoxification treatment. Kidney function and other relevant laboratory markers require attention.

For IV Plaque X, we review the specific product, proposed indication, uncertainties, and alternatives. It is not presented as a proven way to remove arterial plaque or prevent cardiovascular events.

IV antibiotics for selected infections.

For patients being assessed for chronic infections, IV antibiotics may be considered when a bacterial diagnosis and clinical indication support their use. The choice of medication, route, duration, and monitoring is individualized and coordinated with other treating professionals where appropriate.

Persistent symptoms alone do not establish an ongoing bacterial infection. Prolonged IV antibiotics are not an established treatment for persistent symptoms following appropriately treated Lyme disease, and can cause serious complications.

Selected IV medications.

Other medications may be delivered intravenously when there is a specific clinical indication and the IV route is appropriate. Your consultation covers the medication being proposed, its intended role, interactions, potential side effects, and follow-up.

SOT therapy.

Supportive oligonucleotide therapy (SOT) is a specialized, investigational approach discussed separately from routine nutrient and medication infusions. Published studies are preliminary; effectiveness and long-term safety for cancer and chronic infections have not been established.

A discussion includes the proposed product and target, the limitations of current research, risks and unknowns, and established treatment alternatives. SOT is not presented as a proven cure or a replacement for standard oncology or infectious disease care.

Care before, during, and after your infusion.

We review preparation, infusion-specific monitoring, and follow-up based on the treatment selected. IV treatment carries risks, including infusion reactions and IV-site complications; these are considered alongside the possible benefit for your situation.

Discuss IV therapy

Further reading.

Chelation evidence · NCCIH ↗
Risks of prolonged IV antibiotics · CDC ↗
Preliminary SOT infection study ↗ · Preliminary SOT oncology study ↗

Stock photography credits ↗